Through
11/26
New multidisciplinary research involving both psychologists and dermatologists from the Perelman School of Medicine is the first to examine how common this stigma may be among the general population of the United States.
Since 2015, the Hospital of the University of Pennsylvania has supported the Family Caregiver Center, a three-room space that serves an array of needs, from resources to relaxation, for caregivers—one of only a few in the United States.
The European Commission has approved a personalized cellular therapy developed at the Abramson Cancer Center, making it the first CAR T cell therapy permitted for use in the European Union in two distinct indications.
New insights from the Perelman School of Medicine on the origins of deadly infectious diseases are vital to understanding the emergence of human pathogens, and may even lead to eradicating malaria.
A flu vaccine that targets a deeper level of the virus itself may be the key to a universal flu vaccine that is more effective at protecting humans from any strain of flu each season.
More than 150 different mutations in the light-sensing molecule rhodopsin can cause retinitis pigmentosa, characterized by a progressive loss of night and peripheral vision, and a team of researchers have developed a treatment for the condition. Successful results in dogs set the stage for testing in humans.
A new study by Penn Center for Global Health, published in PLOS One, finds that 25 percent of the large indigenous population in Guatemala has either type 2 diabetes or pre-diabetes.
Carl June, a gene therapy pioneer at the Abramson Cancer Center, will receive the 2018 Albany Medical Center Prize in Medicine and Biomedical Research.
Ralph St. Luce & Rotem Kimia, two members of a new class of medical students at the Perelman School of Medicine, discuss what brought them to medicine, in anticipation of the school's annual White Coat Ceremony.
In a study done by researchers at the Perelman School of Medicine and the School of Arts and Sciences, PARP inhibitors, which are used for fighting cancer, can be useful for the treatment and prevention of brain disorders such as ALS.
The National Institutes of Health have awarded $11 million to Aimin Chen of the Perelman School of Medicine to study the link between chemical exposures and dementia.
FULL STORY →
A COVID patient who survived his coma recently reunited with the Penn Medicine care team that helped save his life, including Jennifer Olenik of the Perelman School of Medicine.
FULL STORY →
Research published by Marianne Nabbout while a resident at the Perelman School of Medicine finds that vaping has an immediate effect on blood vessels even if an e-cigarette doesn’t contain nicotine.
FULL STORY →
A former COVID patient who spent six months in a coma returned to thank the Penn Medicine team that contributed to his survival, including Megan Carr-Lettieri.
FULL STORY →
According to Penn Medicine, about 1 in 4 Americans experiences difficulty with sleep each year.
FULL STORY →